Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1/Nrf2-ARE signaling pathway to reduce ferroptosis - Concepedia

Concepedia

Publication | Closed Access

Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1/Nrf2-ARE signaling pathway to reduce ferroptosis

115

Citations

38

References

2021

Year

Gai Gao, Zhishen Xie, Erwen Li, Yong Yuan, Yu Fu, Pan Wang, Xiaowei Zhang, Yonghui Qiao, Jiangyan Xu, Christian Hölscher,

Journal of Natural Medicines

Metabolic SyndromeBiochemistryMedicineLiver PhysiologyLipid PeroxidationMetabolic RegulationLiver DiseaseFatty Liver DiseaseMetabolismPharmacologyDehydroabietic AcidFerroptosisOxidative StressHealth Sciences

References

	Year	Citations

Page 1

Page 1